CSI Market
Sign In | Register

Harvard Bioscience Inc (HBIO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access HBIO Annual Cash Flow →
The quarterly cash flow data below helps track how Harvard Bioscience Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-6.33
Depreciation & amortization0.91
Amortization of Other Assets2.58
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss0.55
Provision For Loan Losses Expensed-0.01
Increase (Decrease) in Inventories1.72
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Business0.00
Share-based Compensation0.64
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability-
Non Cash Restructuring Charge-
Amortization Of Catalog Costs-
Deferred Income Tax Expense Benefit Including Discontinued Operation-0.09
Write Off Of Deferred Debt Issuance Cost-
Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost-
Equity Securities Fv Ni Gain Loss-
Amortization Of Intangible Assets Including Amounts Related To Discontinued Operation0.91
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-1.46
Increase (Decrease) in Accounts Payable and Accrued Liabilities1.56
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.39
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.11
Discontinued operations0.00
Net Cash flow from Operating Activities-0.34
Investing Activities
Capital Expenditures-1.54
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sale Of Discontinued Operations-
Additions To Catalog Costs-
Proceeds From Sale Of Equity Securities Fv Ni-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-1.54
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.13
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-0.07
Other net0.15
Treasury Stock Value Acquired Cost Method-
Transfer Of Cash And Cash Equivalents To H A R T-
Net Taxes Paid Net Proceeds From Issuance Of Common Stock-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.05
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-1.87
Total Cash Flow-2.11
4 historic quarters locked

Sign in to unlock the full Harvard Bioscience Inc cash flow history.

Sign In Create Free Account

About Harvard Bioscience Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001171843-26-005425

Figures are derived from filed reports and may be restated. Historical data is subject to revision.